Expanded Access to 0.5 mg eRapa for Familial Adenomatous Polyposis
NCT07689942
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Familial Adenomatous Polyposis (FAP)
Interventions
DRUG:
eRapa (encapsulated rapamycin)
Sponsor
Biodexa Pharmaceuticals